Paul Domanico | Senior Director of Global Health Sciences,
Clinton Health Access Initiative (CHAI)

Paul Domanico, Senior Director of Global Health Sciences,, Clinton Health Access Initiative (CHAI)

Paul L. Domanico joined CHAI in 2012 as the Senior Director of Global Health Sciences at CHAI. His department partners with industry, academia, and other global health organizations to advance adult and pediatric care, and support CHAI's mission to transform global health. Paul founded Innovalyst in 2007: a life sciences consulting company that catalyzes product development and commercialization in diagnostics and devices, drug discovery and development, and life science informatics. From 2001-2007, Paul was the VP of Technology Development at GSK where his departments developed and commercialized R&D technologies and assessed new investment opportunities. Paul worked at GSK for 19 years. Paul holds a PhD in Chemistry from Penn State University. He received his post-doctoral training in Molecular Biophysics at E.I. du Pont de Nemours.


WVIC/WAC Day 1 - Nov 29 @ 16:50

Are long-acting ARTs the future of HIV prevention and treatment?

  • How can we improve the half-life of long-acting ARTs?
  • How can we enhance the uptake/usage of long-acting formulations?
  • What are the implementation challenges for therapies?
  • What are the key policy issues for these types of therapies?
  • Why can long-acting injectable therapies be difficult to access in LMIC?
last published: 01/Dec/22 17:25 GMT

back to speakers

For conference programme and speaking opportunities:
Lauren Sheppard

For sponsorship and exhibition opportunities:
Thomas Hall